Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
Author:
Funder
Universitat de Girona
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology
Link
http://link.springer.com/content/pdf/10.1186/s12877-018-0857-5.pdf
Reference82 articles.
1. World Health Organization. Dementia. Geneva: WHO; 2015.
2. Jönsson L, Eriksdotter Jönhagen M, Kilander L, et al. Determinants of costs of care for patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2006;21(5):449–59.
3. Jones RW, Lebrec J, Kahle-Wrobleski K, et al. Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): the impact on costs and caregiver outcomes. Dement Geriatr Cogn Disord Extra. 2017;7(1):87–100.
4. Müller WE, Mutschler E, Riederer P. Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer’s dementia. Pharmacopsychiatry. 1995;28(4):113–24.
5. Wenk GL, Danysz W, Mobley SL. MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. Eur J Pharmacol. 1995;293(3):267–70.
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease;Frontiers in Neuroscience;2024-09-11
2. Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation;ACS Chemical Neuroscience;2024-08-19
3. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow;Frontiers in Pharmacology;2024-05-24
4. ALZHEIMER HASTALIĞI, RİSK FAKTÖRLERİ VE TEDAVİ;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-04-18
5. Panax notoginseng saponins prevent dementia and oxidative stress in brains of SAMP8 mice by enhancing mitophagy;BMC Complementary Medicine and Therapies;2024-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3